IRVINE, Calif. -- (Business Wire)
Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has
been filed against Sientra, Inc. (“Sientra” or the “Company”) (NASDAQ: SIEN).
Investors who purchased or otherwise acquired shares between March 18,
2015 and September 24, 2015, inclusive (the “Class Period”) are
encouraged to contact the Firm immediately to discuss their legal
options.
If you purchased shares of Sientra during the Class Period, please
contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman
Avenue, 3rd Floor, Irvine, CA 92612, by telephone: 949-419-3834, or by
email at joon@khanglaw.com.
There has been no class certification in this case. Until certification
occurs, you are not represented by an attorney. You may choose to take
no action and remain a passive class member.
According to the complaint, on September 24, 2015, the Company disclosed
that the U.K.’s Medicines and Healthcare products Regulatory Agency has
suspended distribution of its Silimed products. When the truth was
revealed, shares dropped causing investors harm.
If you purchased shares of Sientra during the Class Period you have
until November 24, 2015, to ask the Court to appoint you as lead
plaintiff. If you wish to learn more about this lawsuit, or if you have
any questions concerning this notice or your rights, please contact Joon
M. Khang, a prominent litigator for almost two decades, by telephone:
949-419-3834, or by email at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151005006504/en/
Contacts:
Khang & Khang LLP
Joon M. Khang, Esq.
Telephone:
949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com
Source: Khang & Khang LLP
© 2024 Canjex Publishing Ltd. All rights reserved.